Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
Analog Devices
ADI
|
+$121M |
| 4 |
United Therapeutics
UTHR
|
+$105M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$238M |
| 2 |
DXC Technology
DXC
|
+$235M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 4 |
NXP Semiconductors
NXPI
|
+$158M |
| 5 |
Baidu
BIDU
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.57% |
| 2 | Healthcare | 20.55% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 7.32% |
| 5 | Communication Services | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Dynatrace
DT
$14.3B
| $11M | 0.05% |
188,026
+92,712
| +97% | +$4.84M |
|
427
Quanta Services
PWR
$92.9B
| $10.9M | 0.05% |
120,800
+80,700
| +201% | +$7.58M |
|
428
Roper Technologies
ROP
$41.1B
| $10.9M | 0.05% |
23,200
-20,052
| -46% | -$8.86M |
|
429
Health Catalyst
HCAT
$119M
| $10.9M | 0.05% |
+196,186
| New | +$10.5M |
|
430
West Pharmaceutical
WST
$24.8B
| $10.8M | 0.05% |
30,128
-16,729
| -36% | -$5.53M |
|
|
SGI
431
Somnigroup International
SGI
$13.5B
| $10.8M | 0.05% |
276,000
-507,000
| -65% | -$19.4M |
|
432
Datadog
DDOG
$81.8B
| $10.8M | 0.05% |
+103,830
| New | +$9.38M |
|
433
Tenet Healthcare
THC
$22.4B
| $10.8M | 0.05% |
161,100
-27,500
| -15% | -$1.71M |
|
434
Children's Place
PLCE
$58.9M
| $10.8M | 0.05% |
115,937
-53,059
| -31% | -$4.51M |
|
435
Eagle Materials
EXP
$6.28B
| $10.8M | 0.05% |
75,800
-49,161
| -39% | -$7.07M |
|
436
iQIYI
IQ
$984M
| $10.7M | 0.05% |
689,700
-3,061,400
| -82% | -$45.5M |
|
437
Evergy
EVRG
$18.7B
| $10.7M | 0.05% |
177,600
-675,086
| -79% | -$42.2M |
|
438
Array Technologies
ARRY
$702M
| $10.7M | 0.05% |
687,218
+1,418
| +0.2% | +$29.9K |
|
439
Transmedics
TMDX
$3.25B
| $10.7M | 0.05% |
+322,000
| New | +$8.92M |
|
440
Driven Brands
DRVN
$2.14B
| $10.6M | 0.05% |
343,500
+91,400
| +36% | +$2.57M |
|
441
Howmet Aerospace
HWM
$104B
| $10.6M | 0.05% |
307,100
-744,500
| -71% | -$24.8M |
|
442
Devon Energy
DVN
$52.9B
| $10.6M | 0.05% |
362,557
-2,546,048
| -88% | -$65.8M |
|
443
Kontoor Brands
KTB
$4.51B
| $10.6M | 0.05% |
187,466
-256,729
| -58% | -$15.7M |
|
|
DESP
444
DELISTED
Despegar.com
DESP
| $10.6M | 0.05% |
800,000
+265,400
| +50% | +$3.57M |
|
445
Liberty Global Class A
LBTYA
$3.66B
| $10.5M | 0.05% |
385,624
+256,424
| +198% | +$6.92M |
|
446
CALL
Caesars Entertainment
CZR
$6.05B
| $10.4M | 0.05% |
100,000
+50,000
| +100% | +$5.04M |
|
|
APLT
447
DELISTED
Applied Therapeutics
APLT
| $10.2M | 0.05% |
492,500
+194,200
| +65% | +$3.68M |
|
448
Allegion
ALLE
$13.8B
| $10.2M | 0.05% |
+73,381
| New | +$10M |
|
|
IEA
449
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $10.2M | 0.05% |
794,052
+290,803
| +58% | +$3.64M |
|
|
NGAB.U
450
DELISTED
Northern Genesis Acquisition Corp. II Units, each consisting of one share of common stock and one-th
NGAB.U
| $10.2M | 0.05% |
974,000
| – | – |
|
Similar funds
Steven Cohen's Q2 2021 Portfolio in Review
As of Q2 2021, Steven Cohen held 1,274 positions worth $22.3B, up 4% from $21.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Steven Cohen's Q2 2021 filing shows 347 new, 260 increased, 248 reduced and 334 closed positions. Its largest new stake was United Therapeutics: 552,400 shares worth $99.1M. The largest sale was Applied Materials, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Steven Cohen's largest Q2 2021 buy was United Therapeutics: 552,400 shares worth $99.1M.
- Steven Cohen added most to Salesforce in Q2 2021, an estimated $372M increase.
- Steven Cohen's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $238M.
- Steven Cohen fully exited DXC Technology in Q2 2021, selling an estimated $235M.
- Steven Cohen's ten largest holdings make up 18% of its $22.3B portfolio in Q2 2021.
- Steven Cohen opened 347 new positions and closed 334 in Q2 2021.
- Steven Cohen's portfolio value rose 4% quarter-over-quarter to $22.3B.
Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.